Rating Change
JP Morgan analysts initiated coverage on Nuvation Bio Inc. (NYSE:NUVB) with a rating of Overweight on August 18, 2026.
new coverageNYSE:NUVB
JP Morgan Initiates Coverage on Nuvation Bio Inc. (NUVB) with Overweight
JP Morgan analysts initiated coverage on Nuvation Bio Inc. (NYSE:NUVB) with a rating of Overweight on August 18, 2026.
At publication ·
What changed
Nuvation Bio Inc. (NYSE:NUVB) · new coverage
- Firm
- JP Morgan
- Rating
- Overweight
- Price at event
- $6.96
- Market capitalization
- $2.8B
At a glance
Key takeaways
- JP Morgan initiated coverage of Nuvation Bio Inc. (NUVB) on August 18, 2026 with an Overweight rating, though no price target was provided.
Market Context
Nuvation Bio Inc. operates in the Healthcare sector. The stock currently trades at $6.96 with a market capitalization of $2.8B.
Analyst coverage from JP Morgan provides professional research and price targets that many institutional investors reference when making allocation decisions. The consensus of analyst opinions — along with the range of price targets — helps frame market expectations for Nuvation Bio Inc.
Analyst ratings and price targets are one input among many for investment decisions. Historical studies show that consensus analyst recommendations have mixed predictive power on their own, but significant changes in consensus — such as multiple upgrades or downgrades in a short period — can be more meaningful signals.
Recent Analyst Activity for Nuvation Bio Inc.
Among the 10 most recent ratings: 10 Buy, 0 Hold, 0 Sell.
| Date | Firm | Rating | Price Target |
|---|---|---|---|
| Aug 18, 2026 | JP Morgan | Overweight | N/A |
| Aug 07, 2026 | RBC Capital | Outperform | N/A |
| Jul 27, 2026 | HC Wainwright & Co. | Buy | N/A |
| Jul 23, 2026 | Wedbush | Outperform | N/A |
| Jul 07, 2026 | RBC Capital | Outperform | N/A |
Related Tools: Analyst Ratings Dashboard | View NUVB Stock Page
Frequently Asked Questions
What does the Overweight rating mean for NUVB?
A rating of Overweight from JP Morgan reflects the analyst's outlook on Nuvation Bio Inc. (NYSE:NUVB). Analyst ratings are one factor investors consider alongside earnings, valuation, and sector trends.
Where can I find more analyst ratings?
Browse recent upgrades and downgrades on our Analyst Ratings Dashboard or the NUVB forecast page.